SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-003476
Filing Date
2024-02-05
Accepted
2024-02-05 19:56:00
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6579
  Complete submission text file 0001127602-24-003476.txt   8156
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG 300 #201 CAMBRIDGE MA 02139
Business Address
Avruch Steven (Reporting) CIK: 0001762236 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 24597690